The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: results and limitations of a registry-linked study.
Ora Paltiel(Hebrew University of Jerusalem), Dina Ben Yehuda(Hadassah Medical Center), Eliezer A. Rachmilevitz(Hadassah Medical Center), Micha Barchana(Israel Ministry of Health), Tal Schmit(Hadassah Medical Center), Ron Epelbaum(University of Bern), Nissim Haim(Technion – Israel Institute of Technology), Ronit Cohen(Hadassah Medical Center), Aaron Polliack(Hadassah Medical Center), Bella Adler(Hadassah Medical Center), Menachem Ben Shachar(Rambam Health Care Campus), Amos Cohen(Hospital for Sick Children)
PubMed
May 15, 2000
Cited by 65
Related Papers
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
|The Lancet|2018|733
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381